Cardiovascular risk associated with acarbose versus metformin as the first-line treatment in patients with type 2 diabetes: a nationwide cohort study (Q41631306)
Jump to navigation
Jump to search
scientific article published on 2 January 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cardiovascular risk associated with acarbose versus metformin as the first-line treatment in patients with type 2 diabetes: a nationwide cohort study |
scientific article published on 2 January 2015 |
Statements
1 reference
Cardiovascular risk associated with acarbose versus metformin as the first-line treatment in patients with type 2 diabetes: a nationwide cohort study (English)
1 reference
Jou-Wei Lin
1 reference
Shu-Ting Chen
1 reference
Lee-Ming Chuang
1 reference
Lee-Ming Chuang
1 reference
2 January 2015
1 reference
1 reference
Identifiers
1 reference